One World ProductsOWPC -8.54% Net Margin % is 10,532.00% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, One World Products ranks better than 99.79% on this metric.
The historical rank and industry rank for One World Products's Net Margin % or its related term are showing as below:
OWPC'
s Net Margin % Range Over the Past 10 Years
Min: -78700 Med: -13275 Max: 7754.72
Current: 7754.72
OWPC's Net Margin % is ranked better than 99.79% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs OWPC: 7754.72
One World Products (OTCPK:OWPC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
One World Products Net Margin % Related Terms
One World Products Net Margin % Historical Data
* Premium members only.
The historical data trend for One World Products's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's Net Margin % distribution charts can be found below:
* The bar in red indicates where One World Products's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
One World Products (OWPC) has a Net Margin % of 10,532.00% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on One World Products and its competitors. According to the industry distribution chart, One World Products ranks #2 out of 956 companies in the Drug Manufacturers industry, placing it in the top 0.2%.
Is One World Products' Net Margin % too high?
One World Products' current Net Margin % is 10,532.00%. The Drug Manufacturers industry median Net Margin % is 5.56. One World Products' value of 10,532.00% is 189324.5% above this industry median. Based on the distribution chart, One World Products ranks #2 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does One World Products' Net Margin % compare to NPHC and PLSH?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #2 out of 956 companies for Net Margin %. This places One World Products in the top 0% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. One World Products' value of 10,532.00% is 189324.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. One World Products's current Net Margin % of 10,532.00% is 189324.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on One World Products and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current Net Margin % is 10,532.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current Net Margin % of 10,532.00%. The current Net Margin % is 10,532.00% and 189324.5% above the Drug Manufacturers industry median of 5.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For One World Products (OWPC), the current Net Margin % is 10,532.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 